Revance Therapeutics, Inc. (RVNC)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 4.2900 |
| Open | 4.0500 |
| Bid | 3.2900 x 500 |
| Ask | 3.3500 x 400 |
| Day's range | 3.0000 - 4.0500 |
| 52-week range | 3.0000 - 35.8300 |
| Volume | |
| Avg. volume | 1,846,272 |
| Market cap | 345.997M |
| Beta (5Y monthly) | 1.15 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.8300 |
| Earnings date | 05 Aug 2024 - 20 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 14.91 |
Insider MonkeyRevance Therapeutics, Inc. (NASDAQ:RVNC) Q1 2024 Earnings Call Transcript
Revance Therapeutics, Inc. (NASDAQ:RVNC) Q1 2024 Earnings Call Transcript May 9, 2024 Revance Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Revance Therapeutics First Quarter2024 Financial Results and Corporate Update Conference Call. At this time, […]
GuruFocus.comRevance Therapeutics Reports Q1 2024 Financial Results: Revenue Growth Amidst Rising Operating ...
Despite Increased Revenues, Revance Faces Higher Operating Costs and a Persistent Net Loss
ZacksRevance Therapeutics, Inc. (RVNC) Reports Q1 Loss, Lags Revenue Estimates
Revance Therapeutics (RVNC) delivered earnings and revenue surprises of 18.18% and 6.66%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.